Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yan Zhan

Showing results (301-310 of 328) with videos related to

Pageof 33
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 16, 2026
FUCA2 Sustains AKT Signaling and Suppresses Senescence by Antagonizing FUT3-Mediated ErbB3 Fucosylation in Lung AdenocarcinomaLu Chen, Jintao Guo, Fei Li, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|December 19, 2024
[Integrated evidence chain: a new strategy and methodology for effectiveness e valuation of traditional Chinese medicines]Xiao-He Xiao, Ye Luo, Xu Zhao, et al.
Cell Host & Microbe|July 25, 2020
Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 PatientsNan Wang, Yan Zhan, Linyu Zhu, et al.
Ophthalmic Epidemiology|October 29, 2013
Design, methodology and baseline data of a school-based cohort study in Central China: the Anyang Childhood Eye StudyShi-Ming Li, Luo-Ru Liu, Si-Yuan Li, et al.
Gut|August 30, 2011
The orphan receptor TR3 suppresses intestinal tumorigenesis in mice by downregulating Wnt signallingHang-Zi Chen, Qing-Feng Liu, Li Li, et al.
JAMA Pediatrics|September 26, 2022
Effect of Text Messaging Parents of School-Aged Children on Outdoor Time to Control Myopia: A Randomized Clinical TrialShi-Ming Li, An-Ran Ran, Meng-Tian Kang, et al.
Acta Pharmacologica Sinica|November 27, 2020
Pharmacokinetics, mass balance, and metabolism of [<sup>14</sup>C]vicagrel, a novel irreversible P2Y<sub>12</sub> inhibitor in humansYuan-Dong Zheng, Hua Zhang, Yan Zhan, et al.
Clinical and Translational Medicine|November 29, 2021
Analytics of the clinical implementation of pharmacogenomics testing in 12 758 individualsYang Wang, Fan Xiao, Yan Chen, et al.
Acta Pharmacologica Sinica|August 2, 2023
Author Correction: Pharmacokinetics, mass balance, and metabolism of [<sup>14</sup>C]vicagrel, a novel irreversible P2Y<sub>12</sub> inhibitor in humansYuan-Dong Zheng, Hua Zhang, Yan Zhan, et al.
Chinese Journal of Integrative Medicine|January 11, 2012
Clinical practice guideline of Chinese medicine for chronic gastritisXu-Dong Tang, Bin Lu, Li-Ya Zhou, et al.
Pageof 33

Showing results (301-310 of 328) with videos related to

Sort By:
Pageof 33
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 16, 2026
FUCA2 Sustains AKT Signaling and Suppresses Senescence by Antagonizing FUT3-Mediated ErbB3 Fucosylation in Lung AdenocarcinomaLu Chen, Jintao Guo, Fei Li, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|December 19, 2024
[Integrated evidence chain: a new strategy and methodology for effectiveness e valuation of traditional Chinese medicines]Xiao-He Xiao, Ye Luo, Xu Zhao, et al.
Cell Host & Microbe|July 25, 2020
Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 PatientsNan Wang, Yan Zhan, Linyu Zhu, et al.
Ophthalmic Epidemiology|October 29, 2013
Design, methodology and baseline data of a school-based cohort study in Central China: the Anyang Childhood Eye StudyShi-Ming Li, Luo-Ru Liu, Si-Yuan Li, et al.
Gut|August 30, 2011
The orphan receptor TR3 suppresses intestinal tumorigenesis in mice by downregulating Wnt signallingHang-Zi Chen, Qing-Feng Liu, Li Li, et al.
JAMA Pediatrics|September 26, 2022
Effect of Text Messaging Parents of School-Aged Children on Outdoor Time to Control Myopia: A Randomized Clinical TrialShi-Ming Li, An-Ran Ran, Meng-Tian Kang, et al.
Acta Pharmacologica Sinica|November 27, 2020
Pharmacokinetics, mass balance, and metabolism of [<sup>14</sup>C]vicagrel, a novel irreversible P2Y<sub>12</sub> inhibitor in humansYuan-Dong Zheng, Hua Zhang, Yan Zhan, et al.
Clinical and Translational Medicine|November 29, 2021
Analytics of the clinical implementation of pharmacogenomics testing in 12 758 individualsYang Wang, Fan Xiao, Yan Chen, et al.
Acta Pharmacologica Sinica|August 2, 2023
Author Correction: Pharmacokinetics, mass balance, and metabolism of [<sup>14</sup>C]vicagrel, a novel irreversible P2Y<sub>12</sub> inhibitor in humansYuan-Dong Zheng, Hua Zhang, Yan Zhan, et al.
Chinese Journal of Integrative Medicine|January 11, 2012
Clinical practice guideline of Chinese medicine for chronic gastritisXu-Dong Tang, Bin Lu, Li-Ya Zhou, et al.
Pageof 33